Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Oct 23, 2022
Date Accepted: May 23, 2023

The final, peer-reviewed published version of this preprint can be found here:

Exposure and Reactions to Cancer Treatment Misinformation and Advice: Survey Study

Lazard A, Nicolla S, Vereen RN, Pendleton S, Charlot M, Tan HJ, DiFranzo D, Pulido M, Dasgupta N

Exposure and Reactions to Cancer Treatment Misinformation and Advice: Survey Study

JMIR Cancer 2023;9:e43749

DOI: 10.2196/43749

PMID: 37505790

PMCID: 10422174

Exposure and reactions to cancer treatment (mis)information and advice: Online survey

  • Allison Lazard; 
  • Sydney Nicolla; 
  • Rhyan N. Vereen; 
  • Shanetta Pendleton; 
  • Marjory Charlot; 
  • Hung-Jui Tan; 
  • Dominic DiFranzo; 
  • Marlyn Pulido; 
  • Nabarun Dasgupta

ABSTRACT

Background:

Cancer misinformation often spread faster and further than true information on social media. Cancer treatment misinformation, or false information about alternative cancer treatments and cures, can harm the psychosocial and physical health of individuals with cancer and their cancer care networks of friends and family. Cancer treatment misinformation can lead to distress, abandoning support, and potentially deviating from evidence-based care. There is a pressing need to learn more about how cancer treatment misinformation is shared and to uncover ways to encourage prosocially intervene to reduce exposure and impact of harmful misinformation.

Objective:

We aimed to better understanding exposure and reactions to cancer treatment misinformation, including willingness to prosocially intervene and intentions to share.

Methods:

We conducted an online survey with an embedded experiment with cancer treatment misinformation among US adults. First, participant reported exposure and reactions to cancer treatment (mis)information in general (saw/heard, source, type of advice, curiosity) and specifically on social media (platform, believability). Second, participants were randomly assigned to view one of three cancer treatment misinformation posts or a control post and reported their willingness to prosocially intervene and intentions to share.

Results:

Among US adult participants (N = 306, Mage = 46), including those with cancer and cancer caregivers, almost one in four (24%) received general advice for alternative ways to treat or cure cancer. Advice was primarily shared through family (39%) and friends (37%) for digestive (31%) and natural (14%) alternative cancer treatments, which generated curiosity among most recipients (75%). Exposure was higher on social media, where more than half (56%) of US adult participants saw cancer treatment (mis)information, primarily on Facebook (40%), YouTube (27%), Instagram (22%), and TikTok (14%), among other platforms. Participants (71%) thought cancer treatment (mis)information was true at least sometimes on social media and many (66%) were likely to share (mis)information posts shown. More promising, three of four participants (77%) were willing to prosocially intervene for the cancer (mis)information posts, including to flag as misinformation (63%) or report to the platform (63%). Individuals with cancer, Black participants, and Hispanic participants reported greater willingness to intervene to reduce cancer misinformation, but also higher intentions to share misinformation.

Conclusions:

Cancer treatment (mis)information is reaching US adults through social media, including on some of the most widely used platforms for support. Many believe social media cancer treatment posts are true at least some of the time. The willingness of US adults, including those with cancer and vulnerable population, to prosocially intervene could initiate the necessary community action to reduce the exposure and impact of cancer treatment misinformation. Clinical Trial: https://aspredicted.org/2WN_3HD


 Citation

Please cite as:

Lazard A, Nicolla S, Vereen RN, Pendleton S, Charlot M, Tan HJ, DiFranzo D, Pulido M, Dasgupta N

Exposure and Reactions to Cancer Treatment Misinformation and Advice: Survey Study

JMIR Cancer 2023;9:e43749

DOI: 10.2196/43749

PMID: 37505790

PMCID: 10422174

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.